Natco gets tentative nod to sell Sorafenib in US
The Dollar Business Bureau Indian drug manufacturer Natco Pharma Ltd said on Friday that its marketing associate Mylan Inc has got tentative approval from the USFDA for marketing generic drug Sorafenib that is used in the treatment of cancer in the US market. “Mylan Inc has got a tentative nod from the USFDA (United States Food and Drug Administration) for its Abbreviated New Drug Application (ANDA) for 200 mg Sorafenib tablets,” Natco Pharma said in a statement. "Natco and Mylan have submitted an application comprising a Paragraph IV certification for Sorafenib tablets," it added. This product has been manufactured by Natco at its Kothur facility in the state of Telangana, the company said. Sorafenib tablets in the strength of 200mg were sold by Onyx ...
Monsanto India records a Q4 net profit at Rs.24.08 crore
The Dollar Business Bureau Monsanto India has reported a net profit of Rs.24.08 crore for the quarter ended March 31, 2016. The high income has helped the company recoup from the loss it was suffering during the same period the previous year. During the same quarter of the previous year, i.e. on March 31, 2015, the company witnessed a net loss of Rs.8.25 crore. The income from the operation increased to Rs.86.85 crore during the January- February quarter of 2015-16 from Rs.67.41 crore during the year-ago period. The total income of the company saw a growth of 31.82% during the quarter ended March 31, 2015. The total income of the company during the quarter has increased to Rs.93.21 crore from Rs.70.71 crore for ...
Bayer offers $62 bn to acquire US based Monsanto
The Dollar Business Bureau Germany based chemical and pharmaceutical company, Bayer AG, has offered an all-cash deal to acquire a US based seeds firm, Monsanto Co, for a total value of $62 billion. Monsanto’s board is still reviewing this unsolicited proposal by consulting with financial and legal advisors. Monsanto Co has a strong presence in India with subsidiary companies namely - Monsanto India Ltd (MIL), Monsanto Holdings Pvt Ltd (MHPL), and another joint venture firm, Mahyco Monsanto Biotech India Ltd (MMBL). These three firms have more than 000 staff and generate huge turnover annually. Bayer is planning to create a leading integrated agri-business with this deal by enhancing its product portfolio and R&D pipeline. It aims to deliver more innovative solutions for farmers. ...
Glenmark Pharmaceuticals receives three ANDA approvals from USFDA
The Dollar Business Bureau Mumbai-based Glenmark Pharmaceuticals on Monday announced that it has got ANDA approvals from the United States Food and Drug Administration (USFDA) for its two oral contraceptives - Levonorgestrel tablet, 1.5 mg and Drospirenone and Ethinyl Estradiol tablets, 3 mg/0.03 mg. “Glenmark Pharmaceuticals Inc. has been granted final approval by the USFDA for Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.03 mg, the generic version of Yasmin tablets of Bayer HealthCare Pharmaceuticals Inc. (Bayer) and for Levonorgestrel tablet, 1.5 mg, the generic version of Plan B One-Step tablet of Teva Branded Pharmaceutical Products R&D, Inc., for over-the-counter (OTC) use as recommended in the submitted labeling,” Glenmark said in a press release. The drug major, however, cautioned the risk ...
